Functional enrichment analysis demonstrated that DEGs of FOXO1 overexpression compared with control (Table S1) were associated with non-alcoholic fatty liver disease, FoxO signaling pathway, cell cycle, and autophagy pathways, closely related to the occurrence and development of HCC (Figure 4F). Here, FOXO1 is linked to metabolic dysfunction-associated steatotic liver disease.